Q. Ebrahem

发表

VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks

Ganga Karunamuni, Michiko Watanabe, Peter K Kaiser, 2009, Anatomical record.

Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus

J. Maciejewski, Harinder Singh, Y. Saunthararajah, 2010, Molecular Cancer Therapeutics.

Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy

J. Sears, Q. Ebrahem, G. Hoppe, 2008, Proceedings of the National Academy of Sciences.

Deletion of HIF-1α partially rescues the abnormal hyaloid vascular system in Cited2 conditional knockout mouse eyes

S. Dunwoodie, Michiko Watanabe, Q. Ebrahem, 2012, Molecular vision.

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2

L. Claesson‐Welsh, Q. Ebrahem, A. Baker, 2003, Nature Medicine.

GPR4 plays a critical role in endothelial cell function and mediates the effects of sphingosylphosphorylcholine

Jing Qiao, H. Lum, Q. Ebrahem, 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Tissue inhibitor of metalloproteinases-3 and Sorsby fundus dystrophy.

Q. Ebrahem, B. Anand-Apte, J. Qi, 2003, Advances in experimental medicine and biology.

Expression of Sorsby's Fundus Dystrophy Mutations in Human Retinal Pigment Epithelial Cells Reduces Matrix Metalloproteinase Inhibition and May Promote Angiogenesis*

K. Yeow, Q. Ebrahem, D. Edwards, 2002, The Journal of Biological Chemistry.

Suppression of apoptosis by TP53 mutation contributes to resistance of acute myeloid leukemia (AML) to conventional cytotoxic treatment. Using differentiation to induce irreversible cell cycle exit in AML cells could be a p53-independent treatment alternative, however, this possibility requires eval

J. Maciejewski, A. Advani, R. Mahfouz, 2011 .

p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

J. Maciejewski, Y. Saunthararajah, A. Advani, 2011, Leukemia.

Runx1 deficiency permits granulocyte lineage commitment but impairs subsequent maturation

Y. Saunthararajah, Q. Ebrahem, Zhenbo Hu, 2013, Oncogenesis.

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects

Y. Saunthararajah, R. Mahfouz, Q. Ebrahem, 2012, Oncotarget.

The Mechanism By Which Mutant Nucleophosmin (NPM1) Creates Leukemic Self-Renewal Is Readily Reversed

B. Falini, J. Maciejewski, Y. Saunthararajah, 2016 .

Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.

M. Parat, Q. Ebrahem, B. Anand-Apte, 2012, The American journal of pathology.

Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy

A. Jankowska, J. Maciejewski, Y. Saunthararajah, 2013, Clinical Cancer Research.

Increased CDA expression / activity in males contributes to decreased cytidine analogue half-life and likely contributes to worse outcomes with 5-azacytidine or decitabine therapy Running title : Gender , cytidine deaminase and 5-aza / decitabine

A. Jankowska, J. Maciejewski, Y. Saunthararajah, 2012 .

Triamcinolone acetonide inhibits IL-6- and VEGF-induced angiogenesis downstream of the IL-6 and VEGF receptors.

J. Sears, Q. Ebrahem, G. Hoppe, 2006, Investigative ophthalmology & visual science.

VESGEN 2D: Automated, User‐Interactive Software for Quantification and Mapping of Angiogenic and Lymphangiogenic Trees and Networks

Terri L. McKay, P. Kaiser, P. Parsons-Wingerter, 2009, Anatomical record.

Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo.

S. Erzurum, Q. Ebrahem, A. Vasanji, 2010, The American journal of pathology.

Runx1 Regulation of Pu.1 Corepressor/Coactivator Exchange Identifies Specific Molecular Targets for Leukemia Differentiation Therapy*

Y. Saunthararajah, R. Mahfouz, Q. Ebrahem, 2014, The Journal of Biological Chemistry.

OlRIGINAL ARTICLE p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia

J. Maciejewski, Y. Saunthararajah, A. Advani, 2011 .

Tissue Inhibitor of Metalloproteinases-3 Peptides Inhibit Angiogenesis and Choroidal Neovascularization in Mice

B. Bell, J. Sears, Q. Ebrahem, 2013, PloS one.

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates

B. Porse, B. Falini, N. Rapin, 2018, The Journal of clinical investigation.

Ligand exchange on gold nanoparticles for drug delivery and enhanced therapeutic index evaluated in acute myeloid leukemia models

Y. Saunthararajah, R. Mahfouz, Q. Ebrahem, 2014, Experimental biology and medicine.

Carboxyethylpyrrole oxidative protein modifications stimulate neovascularization: Implications for age-related macular degeneration

J. Sears, Q. Ebrahem, J. Crabb, 2006, Proceedings of the National Academy of Sciences.

Carboxyethylpyrrole adducts, age-related macular degeneration and neovascularization.

J. Sears, Q. Ebrahem, J. Crabb, 2008, Advances in experimental medicine and biology.

Betacellulin Induces Increased Retinal Vascular Permeability in Mice

J. Folkman, M. Sugimoto, J. Hollyfield, 2010, PloS one.

Increased neovascularization in mice lacking tissue inhibitor of metalloproteinases-3.

R. Khokha, M. Sugimoto, J. Sears, 2011, Investigative ophthalmology & visual science.

Mechanisms of Resistance to 5-Azacytidine/Decitabine in MDS-AML and Pre-Clinical In Vivo Proof of Principle of Rational Solutions to Extend Response

J. Maciejewski, Y. Saunthararajah, H. Carraway, 2015 .

Altered angiogenesis in caveolin-1 gene-deficient mice is restored by ablation of endothelial nitric oxide synthase.

M. Parat, Q. Ebrahem, B. Anand-Apte, 2012, The American journal of pathology.